BALPHARMAPharmaceuticals
Bal Pharma Ltd — PE Ratio & Valuation Analysis
₹60.42
-1.51%
Current P/E17.43xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E31.2x44.2% below avg
✅
45.1% Discount to Industry
BALPHARMA P/E 17.43x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹4.56 | ₹73 | 16.1x |
| 2024 | ₹4.94 | ₹123 | 24.8x |
| 2023 | ₹1.67 | ₹100 | 59.9x |
| 2022 | ₹3.79 | ₹91 | 24.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Bal Pharma Ltd Valuation
Bal Pharma Ltd (BALPHARMA) currently trades at 17.43x earnings. The Pharmaceuticals sector average PE is 31.77x. BALPHARMA is trading at a discount to peers — may indicate relative value. Historically, BALPHARMA has traded at an average PE of 31.2x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
9.66%
Dividend Yield
1.59%
More on Bal Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.